Loading...
Please wait, while we are loading the content...
Similar Documents
How to manage KPC infections
| Content Provider | SAGE Publishing |
|---|---|
| Author | Bassetti, Matteo Peghin, Maddalena |
| Copyright Year | 2020 |
| Abstract | Carbapenemase-producing Enterobacteriaceae represent an increasing global threat worldwide and Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae (KPC-KP) has become one of the most important contemporary pathogens, especially in endemic areas. Risk stratification and rapid diagnostics laboratory workflows are of paramount importance and indication for therapy of KPC-KP infection must be individualized according to the baseline characteristics of the patient and severity of infection. The optimal treatment of infection because of KPC-KP organisms is uncertain and antibiotic options are limited. The knowledge of the patient’s pathophysiology, infection site, and application of the pharmacokinetic/pharmacodynamic principles on the basis of minimum inhibitory concentration (MIC) has progressively gained major relevance. Combination therapies including high-dose meropenem, colistin, fosfomycin, tigecycline, and aminoglycosides are widely used, with suboptimal results. In the past few years, new antimicrobials targeting KPC-KP have been developed and are now at various stages of clinical research. However, their optimal use should be guaranteed in the long term for delaying, as much as possible, the emergence of resistance. Strict infection control measures remain necessary. The aim of this review is to discuss the challenges in the management and treatment of patients with infections because KPC-KP and provide an expert opinion. |
| Related Links | https://journals.sagepub.com/doi/pdf/10.1177/2049936120912049?download=true |
| ISSN | 20499361 |
| Volume Number | 7 |
| Journal | Therapeutic Advances in Infectious Disease (TAI) |
| e-ISSN | 2049937X |
| DOI | 10.1177/2049936120912049 |
| Language | English |
| Publisher | Sage Publications UK |
| Publisher Date | 2020-05-14 |
| Publisher Place | London |
| Access Restriction | Open |
| Rights Holder | © The Author(s), 2020 |
| Subject Keyword | carbapenem-resistant Enterobacteriaceae KPC MDR-GNB multidrug-resistant Gram-negative KPC-KP new antibiotics Klebsiella pneumoniae carbapenemase producing K. pneumoniae |
| Content Type | Text |
| Resource Type | Article |
| Subject | Infectious Diseases Pharmacology (medical) |
